Regarding EGFR status, 48.61% harbored a deletion in exon 19, 45.83% a point mutation in exon 21, 2.78% a point mutation in exon 18, one tumor harbored S768I in exon 20, and another tumor harbored an insertion in exon 20. The gene discussed is EGFR; the disease is neoplasm.